US FDA

New Delhi: Tesla CEO Elon Musk-run brain-computer interface company Neuralink has reportedly received a nod from the US Food and Drug Administration (FDA) to implant its brain chip in a second person. The approval for the second person to have a Neuralink chip came as the first recipient -- Noland Armagh in the US -- detailed his emotional journey. Also ReadNeuralink chip can help restore full body control in people suffering from paralysis: Musk The latest chip in the second recipient comes with some fixes, like embedding some of the device’s ultrathin wires deeper into the brain, The Wall Street Journal reported on Monday. Musk or Neuralink were yet to officially react to the development. The Neuralink chip can help restore full body control in people suffering from paralysis. The company earlier achieved a successful brain-chip implant with Armagh and began the applications for the second participant for the chip implant. According to Musk, the company can bridge "severed nerve signals to a second Neuralink in the spine, restoring full body control”. With the chip in his brain, Arbaugh has enabled "telepathic control of a computer or phone just by thinking". The Neuralink trials aim to assess the initial functionality of the wireless brain-computer interface for enabling people with paralysis to control external devices with their thoughts.

US FDA

US FDA gives nod to Musk’s Neuralink to implant brain chip in 2nd person

India inflicted heavy losses on Pakistan military: Armed Forces

Trump set to accept ‘flying palace’ as gift from Qatar: Report

Pak PM hopes to reinvigorate bilateral ties with US under Trump

Punjab: Schools in five border districts, Sangrur to remain shut on May 12

Congress questions govt on US Kashmir mediation role